HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin and methotrexate.

Abstract
Polymyositis developed in a patient who had received a bone marrow transplant for the treatment of acute lymphoblastic leukemia 20 months earlier. It was a manifestation of chronic graft-versus-host disease associated with sclerodermatous changes of the skin and sicca syndrome. Polymyositis was treated successfully by polyvalent human intravenous immunoglobulin and methotrexate.
AuthorsP Blanche, F Dreyfus, D Sicard
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 1995 May-Jun Vol. 13 Issue 3 Pg. 377-9 ISSN: 0392-856X [Print] Italy
PMID7554569 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dermatologic Agents
  • Immunoglobulins, Intravenous
  • Methotrexate
Topics
  • Chronic Disease
  • Dermatologic Agents (therapeutic use)
  • Drug Therapy, Combination
  • Graft vs Host Disease (complications, diagnosis, drug therapy)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Infusions, Intravenous
  • Male
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Polymyositis (diagnosis, drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: